-
1
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
Published 2019-03-01Subjects: Get full text
Article -
2
Characterisation of IGF-1 (rs7136446) and IL-6 (rs1800795) polymorphisms among breast cancer patients in western Algeria
Published 2024-10-01Subjects: Get full text
Article -
3
High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
Published 2025-01-01Subjects: “…hormone receptors human epidermal growth factor receptor 2 (HER2)…”
Get full text
Article